ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
拨康视云-B
5.300
+0.120
2.32%
手动刷新
成交量:
55.85万
成交额:
297.73万
市值:
44.46亿
市盈率:
-3.26
高:
5.390
开:
5.200
低:
5.200
收:
5.180
52周最高:
9.740
52周最低:
4.930
股本:
8.39亿
香港流通股本:
8.39亿
量比:
0.51
换手率:
0.07%
股息:
- -
股息率:
- -
每股收益(LYR):
-1.628
净资产收益率:
--
总资产收益率:
-44.38%
市净率:
-1.62
市盈率(LYR):
-3.26
市销率:
56.96
数据加载中...
总览
公司
新闻
公告
Cloudbreak Pharma Inc.(拨康视云)通过港交所上市聆讯
每日经济新闻
·
06/21
新股解读|核心产品CBT-001商业化还要等多久?拨康视云3年烧钱21亿再战港股
智通财经
·
06/16
拨康视云-B,递交招股书,拟赴香港上市 | 未盈利生物科技.IPO上市
港澳IPO上市
·
06/15
新股消息 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元
金融界
·
06/11
新股消息 | 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元
智通财经
·
06/11
新股消息 | 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元
智通财经
·
06/11
据港交所文件,拨康视云再次向港交所提交上市申请书,联席保荐人为建银国际、华泰国际。
美港电讯
·
06/11
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02592/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"拨康视云-B","latestPrice":5.3,"timestamp":1756194098734,"preClose":5.18,"halted":0,"volume":558500,"delay":0,"floatShares":838892874,"shares":838892874,"eps":-1.6277027554445398,"marketStatus":"交易中","change":0.12,"latestTime":"08-26 15:43:51","open":5.2,"high":5.39,"low":5.2,"amount":2977340,"amplitude":0.03668,"askPrice":5.3,"askSize":75000,"bidPrice":5.29,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":-1.6277027554445398,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":5.18,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.510745,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":838892874,"roa":"-44.38%","roe":"--","lyrEps":-1.627703,"volumeRatio":0.510745,"shares":838892874,"dividePrice":0,"high":5.39,"amplitude":0.03668,"preClose":5.18,"low":5.2,"week52Low":4.93,"pbRate":"-1.62","psRate":"56.96","week52High":9.74,"institutionHeld":0,"latestPrice":5.3,"committee":-0.960784,"eps":-1.6277027554445398,"divideRate":0,"volume":558500,"delay":0,"ttmEps":-1.6277027554445398,"open":5.2,"prevYearClose":10.1,"prevWeekClose":5.11,"prevMonthClose":5.35,"prevQuarterClose":10.1,"fiveDayClose":5.54,"twentyDayClose":5.6,"sixtyDayClose":10.1,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2025-08-25","current":-5.611715,"percent":0.72973,"low":-6.683808,"twenty":-6.312981,"median":-6.000684,"eighty":-5.556503,"high":-5.433303,"avg":-5.949854,"sd":0.371248,"marketCap":4345465087},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-25","current":-5.611715,"twenty":-6.312981,"median":-6.000684,"eighty":-5.556503,"marketCap":4345465087}],"updateTime":1756186925515},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545488293","title":"Cloudbreak Pharma Inc.(拨康视云)通过港交所上市聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2545488293","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545488293?lang=zh_cn&edition=fundamental","pubTime":"2025-06-21 16:35","pubTimestamp":1750494907,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K2JEDFHE0512B07B.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K2JEDFHE0512B07B.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2543537676","title":"新股解读|核心产品CBT-001商业化还要等多久?拨康视云3年烧钱21亿再战港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543537676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543537676?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 18:13","pubTimestamp":1750068781,"startTime":"0","endTime":"0","summary":"据招股书,拨康视云一般及行政开支由2023年的0.11亿美元减少约180万美元或15.9%至2024年的约950万美元。CBT-001截至最后实际可行日期,并无临时数据可供分析。弗若斯特沙利文报告显示,CBT-001对应的全球治疗翼状胬肉药物的市场规模预计将于2027年达到273.4百万美元及于2032年达到2,529.4百万美元,复合年增长率为56.0%。然而,作为距离商业化最近的产品CBT-001,拨康视云已将部分权益让渡给远大医药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","YANG","BK4090","HSTECH","BK4614","02592","HSCEI"],"gpt_icon":1},{"id":"2543139266","title":"拨康视云-B,递交招股书,拟赴香港上市 | 未盈利生物科技.IPO上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2543139266","media":"港澳IPO上市","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543139266?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 21:37","pubTimestamp":1749994620,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI1NTA3NDA2MA==&mid=2247502333&idx=2&sn=fe4c5036cac8e7d12e8014a87977047e&chksm=ebd191138188ae7db3c2a8937bddb4a3b1545aa77b12084504c65adab87111f87c6788fc9973&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02592"],"gpt_icon":0},{"id":"2542581692","title":"新股消息 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542581692","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542581692?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 19:53","pubTimestamp":1749642806,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1Q1PE0P0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1Q1PE0P0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2542589196","title":"新股消息 | 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542589196","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542589196?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 19:25","pubTimestamp":1749641115,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1Q05QEJ05198UNI.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1Q05QEJ05198UNI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02592"],"gpt_icon":0},{"id":"2542586765","title":"新股消息 | 眼科生物科技公司拨康视云四次递表港交所 2024年亏损约0.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542586765","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542586765?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 19:09","pubTimestamp":1749640178,"startTime":"0","endTime":"0","summary":"拨康视云首家主要营运实体Cloudbreak USA于2015年9月在美国注册成立及公司于2020年11月在开曼群岛注册成立。潜在市场及竞争格局方面,全球眼科药物市场规模由2019年的337亿美元增加至2023年的396亿美元,复合年增长率为4.1%。业绩方面,于2022年度、2023年度及2024年度,拨康视云年内亏损分别约为0.67亿美元、1.29亿美元、0.99亿美元,此外,2024年收益约为1000万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1304061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","02592"],"gpt_icon":0},{"id":"2542758862","title":"据港交所文件,拨康视云再次向港交所提交上市申请书,联席保荐人为建银国际、华泰国际。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542758862","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542758862?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 18:03","pubTimestamp":1749636205,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02592","HEXmain"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":67,"code":"91000000","status":"200"}]}}